Literature DB >> 3039283

Hepatocellular carcinoma associated with second primary malignancy.

D Y Lin, Y F Liaw, C S Wu, C S Chang-Chien, P C Chen, T J Chen.   

Abstract

In a consecutive series of 562 patients with pathologically documented hepatocellular carcinoma (HCC), 12 patients (2.1%) were found to have a second primary malignancy elsewhere. Of these, eight were male, four female, with ages ranging from 49 to 76 years (mean 60.7 +/- 9.3 years). The associated cancers included eight cases of gastric cancers, an esophageal cancer, a stump cancer, a case of myelocytic leukemia and a histiocytic lymphoma. Eight cases had both malignancies diagnosed at the same admission. In the other four, HCC were detected after an interval of 4, 10, 12 and 39 months. Two had received previous chemotherapy or radiotherapy. Fifty percent of the 12 patients were hepatitis B surface antigen (HBsAg) positive. Their liver function tests and alpha-fetoprotein levels were consistent with those of patients with HCC alone. The results suggest that the occurrence of HCC concomitant with or arising after another primary malignancy in Taiwan is not rare.

Entities:  

Mesh:

Year:  1987        PMID: 3039283     DOI: 10.1111/j.1600-0676.1987.tb00325.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  10 in total

1.  Malignant lymphoma of the stomach after chemotherapy for hepatocellular carcinoma.

Authors:  I Matsuo; K Omagari; N Ikuno; H Kinoshita; Y Onizuka; M Itsuno; T Nakayama; S Kohno
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 2.  Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma.

Authors:  A Lonardo; P Tarugi; G Ballarini; A Bagni
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

3.  The surgical management of synchronous hepatocellular carcinoma and thoracic esophageal carcinoma.

Authors:  R Shimizu; T Murakami; K Wadamori; K Yano; T Suzuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

4.  The clinical characteristics of patients with synchronous squamous cell carcinoma of the esophagus and hepatocellular carcinoma.

Authors:  M Morita; H Kuwano; Y Toh; H Matsuda; T Matsumata; K Sugimachi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

5.  Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study.

Authors:  Qing-An Zeng; Jiliang Qiu; Ruhai Zou; Yijie Li; Shengping Li; Binkui Li; Pinzhu Huang; Jian Hong; Yun Zheng; Xiangming Lao; Yunfei Yuan
Journal:  BMC Cancer       Date:  2012-04-17       Impact factor: 4.430

6.  Prevalence and outcomes of extrahepatic primary malignancy associated with hepatocellular carcinoma in a Korean population.

Authors:  Sukho Hong; Sook-Hyang Jeong; Sang Soo Lee; Jung Wha Chung; Sung Wook Yang; Seong Min Chung; Eun Sun Jang; Jin-Wook Kim; Jee Hyun Kim; Haeryoung Kim; Jai Young Cho; Yoo-Seok Yoon; Ho-Seong Han
Journal:  BMC Cancer       Date:  2015-03-18       Impact factor: 4.430

7.  Analysis of Extrahepatic Multiple Primary Malignancies in Patients with Hepatocellular Carcinoma according to Viral Infection Status.

Authors:  Keita Kai; Atsushi Miyoshi; Kenji Kitahara; Masanori Masuda; Yukari Takase; Kohji Miyazaki; Hirokazu Noshiro; Osamu Tokunaga
Journal:  Int J Hepatol       Date:  2012-12-01

8.  Intracranial metastasis in a patient with hepatocellular carcinoma and gastric cancer.

Authors:  Akinobu Tawada; Tetsuhiro Chiba; Yoshihiko Ooka; Hajime Yokota; Naoya Kanogawa; Tenyu Motoyama; Tomoko Saito; Sadahisa Ogasawara; Eiichiro Suzuki; Naoyuki Hanari; Hisahiro Matsubara; Naokatsu Saeki; Michiyo Kambe; Takashi Kishimoto; Yukio Nakatani; Osamu Yokosuka
Journal:  Case Rep Oncol       Date:  2014-03-14

9.  Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival.

Authors:  Kwong Ming Kee; Jing-Houng Wang; Chih-Chi Wang; Yu-Fan Cheng; Sheng-Nan Lu
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

10.  SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer.

Authors:  Yu-De Chu; Kwong-Ming Kee; Wey-Ran Lin; Ming-Wei Lai; Sheng-Nan Lu; Wen-Hung Chung; See-Tong Pang; Chau-Ting Yeh
Journal:  Biomedicines       Date:  2021-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.